UC San Francisco and Berkeley Lights Inc. form collaboration

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UC SAN FRANCISCO and Berkeley Lights Inc. formed a collaboration that gives UCSF researchers access to Berkeley Lights’ opto-nanofluidic biosystems, including single-cell genomic profiling of pre-annotated tissue samples, the development of precision diagnostics, and point-of-care therapies. Through the collaboration, UCSF researchers will study various cancer types to better understand the characterization and functionality of cell...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login